Atypical Antipsychotics in the Treatment of Delusional Parasitosis

Annals of Clinical Psychiatry

Volumn 15, Issue 3-4, 2003, Pages 233-239

  Wenning, Michael T ^a   Davy, Leigh E ^a   Catalano, Glenn ^a,c   Catalano, Maria C ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atypical antipsychotics; Delusional parasitosis; Dopamine; Pimozide; Serotonin

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ATYPICAL ANTIPSYCHOTIC AGENT; BICALUTAMIDE; BUSPIRONE; CLONAZEPAM; DONEPEZIL; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUOXETINE; LITHIUM; PIMOZIDE; QUETIAPINE; RISPERIDONE; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; DELUSIONAL DISORDER; DELUSIONAL PARASITOSIS; DISEASE COURSE; DRUG CHOICE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR DEPRESSION; MALE; PANIC; PARASITOSIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PSYCHOPHARMACOTHERAPY; SEDATION; SIDE EFFECT; SUICIDAL BEHAVIOR; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COMORBIDITY; DELUSIONS; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ECTOPARASITIC INFESTATIONS; FEMALE; HELMINTHIASIS; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; REFERRAL AND CONSULTATION; RISPERIDONE; SHARED PARANOID DISORDER; TREATMENT OUTCOME;

EID: 0842305757     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:ACLI.0000008687.21295.8a     Document Type: Article

References (31)

1. Munro A: Monosymptomatic hypochondriacal psychosis. Br J Hosp Med 1980; 24:34-38
2. Koo JYM, Gambla G: Psychodermatology: Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis; general discussion and case illustrations. Dermatol Clin 1996; 14(3):429-438
3. Bhatia M, Jagawat T, Choudhary S: Delusional parasitosis: A clinical profile. Int J Psychiatry Med 2000; 30(1):83-91
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn., text rev. Washington, DC: American Psychiatric Association; 2000:323-329
5. Reilly TM, Batchelor DH: The presentation and treatment of delusional parasitosis: A dermatologic perspective. Int Clin Psychopharmacol 1986; 1:340-353
6. Wykoff RF: Delusions of parasitosis: A review. Rev Infect Dis 1987; 9:433-437
7. Lell A: The Michelson lecture, delusion of parasitosis. Br J Dermatol 1983; 108:485-499
8. Trabert W: Shared psychotic disorder in delusional parasitosis. Psychopathology 1999; 32:30-34
9. Trabert W: 100 years of delusional parasitosis. Psychopathology 1995; 28:238-246
10. Berrios GE: Delusional parasitosis and physical disease. Compr Psychiatry 1985; 26:395-403
11. Baker PB, Cook BI, Winokur G: Delusional infestation. Psychiatr Clin North Am 1995; 18:345-361
12. May WW, Terpenning MS: Delusional parasitosis in geriatric patients. Psychosomatics 1991; 32:88-94
13. Musalek M, Bach M, Passweg V, Jaeger S: The position of delusional parasitosis in psychiatric nosology and classification. Psychopathology 1990; 23:115-124
14. Rasanen P, Erkonen K, Isaksson U, Koiio P, Varis R, Timonen M, Leinonen E, Isohanni M, Alanko A: Delusional parasitosis in the elderly: A review and report of six cases from northern Finland. Int Psychogeriatr 1997; 9(4):459-464
15. Zomer SF, De Wit RF, Van Bonswijik JE, Nabarro G, Van Vloten WA: Delusions of parasitosis: A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998; 138:1030-1032
16. Richelson E: Receptor pharmacology and neuroleptics: Relation to clinical effects. J Clin Psychiatry 1999; 60:5-14
17. Elmer KB, Georg RM, Peterson K: Therapeutic update: Use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Am Acad Dermatol 2000; 43:683-686
18. Riding BE, Munro A: Pimozide in monosymptomatic delusional parasitosis. Lancet 1975; 1:400-401
19. Monro A, Mok H: An overview of treatment in paranoia/delusional disorder. Can J Psychiatry 1995; 40:616-622
20. Hanumantha K, Pradhan PV, Suvarna B: Delusional parasitosis - Study of 3 cases. J Postgrad Med 1994; 40:222-224
21. Johnson GC, Anton RF: Pimozide in delusions of parasitosis. J Clin Psychiatry 1983; 44:233
22. King BH: Hypothesis: Involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis. Pharmacopsychiatry 1990; 23:85-89
23. DeLeon OA, Furmaga KM, Canterbury AL, Baily LG: Risperdone in the treatment of delusions of infestation. Int J Psychiatry Med 1997; 27:403-409
24. Kitamura H: A case of somatic delusional disorder that responded to treatment with risperidone. Psychiatry Clin Neurosci 1997; 51(5):337
25. Songer DA, Roamn B: Treatment of somatic delusional disorder with atypical antipsychotic agents. Am J Psychiatry 1996; 153:578-579
26. Heym J, Jacobs BL: Serotonergic mechanisms of hallucinogenic drug effects. Monogr Neural Sci 1987; 13:55-81
27. Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS: Delusional parasitosis: A dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993; 29:1023-1033
28. Peroutka SJ, Snyder SH: Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980; 137(12):1518-1522
29. Bymaster FP: In vitro and in vivo biochemistry of olanzapine. J Clin Psychiatry 1997; 15(2):10-12
30. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibition-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57:794-801
31. Stein DJ, Bouwer MB, Hawkridge S, Emsley RA: Risperdone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 1997; 58:119-122